DEXYANE MeD
Palpebral
Treats and limits the recurrence of eczema lesions. Tested under dermatological control. Medical device
DEXYANE MeD
Palpebral
Treats eczema lesions - Soothes itchiness - Decongests - Soothes Medical device
A medical device that treats atopic or contact eczema on the eyelids.
-
Treats and limits the recurrence of eczema lesions.
-
Treats and limits the recurrence of eczema lesions. Tested under dermatological control.
Usable by Infants - Children - Family - Adults
Age From 3 month(s)
Suitable Eyelids
Skin type Eyelid eczema
Need Anti-eczema
Made in France
DEXYANE MED Palpebral is a medical device* for treating localised atopic and/or contact eczema on the eyelids.
Its formula, specially adapted to respect the delicate skin of the eyelids, acts as an ultra-hydrating dressing.
It instantly soothes itching sensations** and reduces burning sensations**.
DEXYANE MED Palpebral restores the skin barrier and corrects dryness.
It can be used as a stand-alone treatment, in combination with, or as a follow-up to topical corticosteroids.
Clinically proven effectiveness.
Benefit
DEXYANE MED Palpébral relieves inflammatory eczema lesions on the eyelids.
Benefits
• SOOTHES itching
• COMFORTS immediately and decongests
• LIMITS the recurrence of eczema lesions
Product scent
Fragrance-free
*DEXYANE MED Palpebral is a medical device, a regulated health product which carries, in accordance with this regulation, the CE mark. Carefully read the instruction leaflet provided. Do not use if pregnant or breastfeeding. Avoid direct contact with the eyes. Age 3 months and up. Manufacturer : Pierre Fabre Medicament.
**Result of a clinical study conducted on 33 adults from 19-70 years old with mild to moderate atopic or contact eyelid eczema. DEXYANE MED Palpebral was applied twice a day to the eyelids for 22 days. The clinical severity score (including itching, burning, tightness, etc.) from 0 to 9, immediately after 3 days of application, was compared to the pre-application scores. Immediately, the itching score significantly decreased, and the burning score improved by day 3. The overall development of lesions was evaluated by the PGA score on a 5-point scale : 0 (aggravation) to 4 (completely healed); after 3 days of application, the majority of patients felt an improvement. PFDC study PRM03-F-197_V3_AN. 03/2019. 98-104, 108.
*DEXYANE MED Palpebral is a medical device, a regulated health product which carries, in accordance with this regulation, the CE mark. Carefully read the instruction leaflet provided. Do not use if pregnant or breastfeeding. Avoid direct contact with the eyes. Age 3 months and up. Manufacturer : Pierre Fabre Medicament.
Environmental impact
Formula
Biodegradable formula*
85.0% natural origin ingredients
*According to a OECD 301 test or Biodegradability index method
Packaging
Not recyclable packaging
Manufacturing
Made and packaged in a factory certified for the environment***
***according to ISO 14001 and/or 50001 standards
Transportation
Societal impact
Societal impact
Product manufactured and packaged in a factory meeting French social standards
Ducray is a brand of the Pierre Fabre Group, certified at the highest Exemplary level of AFNOR Certification’s Committed to CSR and Responsibility Europe labels, thus consolidating a long-standing commitment to contributing to sustainable development.
Everything you need to know about itchy skin or pruritus
- What do you need to know about eczema?
- What causes eczema?
Symptoms of an eczema attack
Diagnosis: Do you have patches, dandruff, redness, itching?
What is infant eczema?
Living with eczema on a daily basis - Areas affected by eczema
- Eczema in children
- How is eczema treated?
- Occupational dermatitis
Application tips
Application areaApply a thin layer directly to the inflammatory lesions of eyelid eczema with a clean finger, avoiding contact with the eye.
Precautions for useAvoid contact with eyes
- Precautions for use
Keep out of reach of children
